Clinical Trial Update: Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 head-to-head trial comparing aripiprazole once-monthly and paliperidone palmitate in adults with schizophrenia, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Aripiprazole Once Monthly (aripiprazole)
• Paliperidone palmitate (Paliperidone palmitate)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2015-12-03